Company Filing History:
Years Active: 2005
Title: Innovations by Jennifer L Che in Antagonists of Melanin Concentrating Hormone Receptor
Introduction
Jennifer L Che is an accomplished inventor based in Cambridge, MA. She holds a patent that contributes significantly to the field of pharmacology, specifically targeting melanin concentrating hormone receptor-1 (MCH-R1). Her groundbreaking work aims to address overweight conditions, including obesity, through innovative compounds.
Latest Patents
Jennifer's patent, titled "Antagonists of Melanin Concentrating Hormone Receptor," reflects her expertise in creating compounds that effectively act as antagonists for MCH-R1. The invention outlines compounds characterized by a specific formula, where parameters such as m, n, Y, R, and Ring A are systematically defined. Notably, preferred compounds include those derived from coumarin and quinolone, particularly where R and R combine to form a fused benzo ring. The patent also introduces alternatives, incorporating a quinazolinone ring in place of the coumarin moiety. These compounds hold immense potential in treating MCH-R1-related disorders.
Career Highlights
Jennifer L Che is affiliated with Abbott Laboratories, a leading company in the healthcare sector. Her work at Abbott has been instrumental in advancing drug discovery and development, particularly in relation to metabolic disorders. With a strong focus on innovation, she has demonstrated a commitment to enhancing therapeutic options available to patients grappling with obesity and related health issues.
Collaborations
Throughout her career, Jennifer has collaborated with notable colleagues, including Christopher Blackburn and Su-Jen Lai. These partnerships reflect a collaborative spirit in research, combining diverse expertise to achieve significant breakthroughs in their field.
Conclusion
Jennifer L Che exemplifies the impact that innovative inventions can have in healthcare. Her patent regarding MCH-R1 antagonists not only showcases her inventive skills but also her dedication to solving critical health challenges, particularly obesity. With continued research and collaborative efforts, her contributions could pave the way for effective treatments in the future.